Association of CYP24A1 Gene Polymorphism with Colorectal Cancer in the Jiamusi Population

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2021 Jun 30

PMID 34191826

Citations 5

Authors

Lin Chai

Jian Ni

Xiaolin Ni

Nan Zhang

Yang Liu

Zhiwu Ji

Xingwang Zhao

Xiaowen Zhu

Bin Zhao

Guorong Xin

Yu Wang

Fan Yang

Liang Sun

Xiaoquan Zhu

Wenhua Bao

Xiaofang Shui

Fengling Wang

Fujun Chen

Ze Yang

Affiliations

Soon will be listed here.

Abstract

Background: The population in Jiamusi has been reported to have the highest prevalence of colorectal cancer (CRC) in China. The genetic causal-effect for this occurrence among the residents remains unclear. Given the long cold seasons with people wearing more clothes and reduced UV exposure, we aimed to study the association between the vitamin D metabolism-related gene CYP24A1 polymorphism and CRC susceptibility.

Method: A case-control study was conducted that included 168 patients with CRC and 710 age-matched healthy individuals as the control group. Plausible susceptible variations were sought and clinical phenotypic-genotype association analysis was performed.

Results: Overall, two CYP24A1 polymorphisms, rs6013905 AX (P = 0.02, OR = 1.89, 95%CI: 1.09-3.29) and rs2762939 GX (P = 0.02, OR = 1.52, 95%CI: 1.08-2.13) were significantly associated with CRC in the Jiamusi population. In the female group, three CYP24A1 polymorphisms, rs6013905 AX (P = 0.04, OR = 2.59, 95%CI: 1.03-6.49), rs2762939 GX (P = 0.01, OR = 2.35, 95%CI: 1.25-4.42), and rs6068816 GG (P = 0.05, OR = 1.89, 95%CI: 0.99-3.59) carriers were significantly associated with CRC. In clinical phenotypic-genotype analysis, rs6013905 GG (P = 0.05, OR = 4.00, 95%CI: 0.92-17.48) and rs2762939 GX (P = 0.03, OR = 4.87, 95%CI: 1.00-23.69) carriers were significantly associated with poorly differentiated CRC, while CYP24A1 rs6068816 AX was significantly associated with the tumor type (P = 0.02, OR = 2.08, 95%CI: 1.10-3.96) and location (P = 0.04, OR = 2.24, 95%CI: 1.05-4.77).

Conclusion: CYP24A1 gene polymorphism may be a genetic risk factor attributable to the highest prevalence of CRC in Jiamusi people. Individuals with CYP24A1 gene polymorphism may have an increased barrier for vitamin D absorption, thus contributing to the risk of CRC development.

Citing Articles

Associations Between Polymorphisms of Genes Related to Vitamin D Pathway and the Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease.

Cusato J, Ribaldone D, D Avolio A, Infusino V, Antonucci M, Caviglia G J Clin Med. 2024; 13(23).

PMID: 39685734 PMC: 11642376. DOI: 10.3390/jcm13237277.

Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.

Zhang T, Hu B, Xu S, Wang Y, Zhang H, Li X Biochem Genet. 2024; .

PMID: 38642176 DOI: 10.1007/s10528-024-10771-z.

Capsaicin and Cold exposure promote EMT-mediated premetastatic niche formation to facilitate colorectal cancer metastasis.

Nong F, Xing S J Cancer. 2024; 15(2):356-369.

PMID: 38169517 PMC: 10758030. DOI: 10.7150/jca.83985.

Vitamin D metabolism in cancer: potential feasibility of vitamin D metabolism blocking therapy.

Kamiya S, Nakamori Y, Takasawa A, Takasawa K, Kyuno D, Ono Y Med Mol Morphol. 2023; 56(2):85-93.

PMID: 36749415 DOI: 10.1007/s00795-023-00348-x.

Association of CYP24A1 with survival and drug resistance in clinical cancer patients: a meta-analysis.

Zeng R, Li H, Jia L, Lee S, Jiang R, Zhang Y BMC Cancer. 2022; 22(1):1317.

PMID: 36527000 PMC: 9756477. DOI: 10.1186/s12885-022-10369-x.

References

Feldman D, Krishnan A, Swami S, Giovannucci E, Feldman B . The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014; 14(5):342-57. DOI: 10.1038/nrc3691. View

Kelly J, Drake M, Fredericksen Z, Asmann Y, Liebow M, Shanafelt T . Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012; 23(7):1017-29. PMC: 3589750. DOI: 10.1007/s10552-012-9967-0. View

Muindi J, Adjei A, Wu Z, Olson I, Huang H, Groman A . Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Horm Cancer. 2013; 4(4):242-50. PMC: 3689467. DOI: 10.1007/s12672-013-0139-9. View

Jones G, Prosser D, Kaufmann M . 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2011; 523(1):9-18. DOI: 10.1016/j.abb.2011.11.003. View

Bokhari A, Lee L, Raboteau D, Turbov J, Rodriguez I, Pike J . Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget. 2016; 7(47):77576-77590. PMC: 5363606. DOI: 10.18632/oncotarget.12725. View

Mariotto A, Yabroff K, Shao Y, Feuer E, Brown M . Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103(2):117-28. PMC: 3107566. DOI: 10.1093/jnci/djq495. View

Horvath H, Lakatos P, Kosa J, Bacsi K, Borka K, Bises G . The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis. J Histochem Cytochem. 2009; 58(3):277-85. PMC: 2825493. DOI: 10.1369/jhc.2009.954339. View

Deeb K, Trump D, Johnson C . Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7(9):684-700. DOI: 10.1038/nrc2196. View

Keum N, Giovannucci E . Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019; 16(12):713-732. DOI: 10.1038/s41575-019-0189-8. View

10.

Sun H, Wang C, Hao M, Sun R, Wang Y, Liu T . CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer. Hum Pathol. 2016; 50:101-8. DOI: 10.1016/j.humpath.2015.11.008. View

11.

Chen X, Mao J, Li W, Li J, Yang H, Qian J . Association between polymorphisms and the risk of colonic polyps and colon cancer in a Chinese population. World J Gastroenterol. 2017; 23(28):5179-5186. PMC: 5537184. DOI: 10.3748/wjg.v23.i28.5179. View

12.

Albertson D, Ylstra B, Segraves R, Collins C, Dairkee S, Kowbel D . Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet. 2000; 25(2):144-6. DOI: 10.1038/75985. View

13.

Sun H, Jiang C, Cong L, Wu N, Wang X, Hao M . CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)D Through Downregulation of the WNT/β-Catenin Pathway and Methylation-Mediated Regulation of CYP24A1 in Colorectal Cancer Cells. DNA Cell Biol. 2018; 37(9):742-749. DOI: 10.1089/dna.2017.4058. View

14.

Chen G, Kim S, King A, Zhao L, Simpson R, Christensen P . CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin Cancer Res. 2010; 17(4):817-26. PMC: 3058389. DOI: 10.1158/1078-0432.CCR-10-1789. View

15.

Wu X, Cheng J, Yang K . Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk. Int J Mol Sci. 2016; 17(10). PMC: 5085630. DOI: 10.3390/ijms17101597. View

16.

Jonsson B, Hofmarcher T, Lindgren P, Wilking N . The cost and burden of cancer in the European Union 1995-2014. Eur J Cancer. 2016; 66:162-70. DOI: 10.1016/j.ejca.2016.06.022. View

17.

Ramnath N, Daignault-Newton S, Dy G, Muindi J, Adjei A, Elingrod V . A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol. 2013; 71(5):1173-82. PMC: 3637851. DOI: 10.1007/s00280-013-2109-x. View

18.

Chen W, Li H, Sun K, Zheng R, Zhang S, Zeng H . [Report of Cancer Incidence and Mortality in China, 2014]. Zhonghua Zhong Liu Za Zhi. 2018; 40(1):5-13. DOI: 10.3760/cma.j.issn.0253-3766.2018.01.002. View

19.

Shen H, Bielak L, Ferguson J, Streeten E, Yerges-Armstrong L, Liu J . Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2010; 30(12):2648-54. PMC: 2988112. DOI: 10.1161/ATVBAHA.110.211805. View

20.

Whitlatch L, Young M, Schwartz G, Flanagan J, Burnstein K, Lokeshwar B . 25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer. J Steroid Biochem Mol Biol. 2002; 81(2):135-40. DOI: 10.1016/s0960-0760(02)00053-5. View